>2. Method of operation>(1) Take 20 pieces of the test product, accurately weigh the total weight, and obtain the average piece weight . >
UV Identification of Bilirubin in Compound Tianwu Tablet and Artificial Bezoar
Time of Update: 2022-06-19
Attachment: Bilirubin[Identification] Take the solution under [Assay] according to the 2015 edition of "Chinese Pharmacopoeia" four-part ultraviolet-visible spectrophotometry (General Rule 0401), measure the absorption curve at the wavelength of 400~500nm, and compare it with the bilirubin reference substance.
Identification of borneol micro-sublimation in Shensu Wan's Qianhu and Niuhuang Jiedu Tablets and borneol micro-sublimation in Wanying Tablets
Time of Update: 2022-06-17
Observe the sublimation object under a microscope: it is an indeterminate colorless flake crystal, add 1 drop of a newly prepared 1% vanillin sulfuric acid solution, and it will gradually become purple-red (borneol) .
Check the weight difference of compound Danshen tablets, check the disintegration time limit of Niuhuang Jiedu tablets (sugar-coated tablets)
Time of Update: 2022-06-15
294Table 19-6 Weight difference inspection and weighing of compound Danshen tablets The standard stipulates: no more than 2 pieces exceeding the weight difference limit, and no piece exceeding the limit by 1 time .
UV Identification of Baoxin Tablets, Paper Chromatography Identification of Huazheng Huisheng Tablets and TLC Identification of Niuhuang Jiedu Pills
Time of Update: 2022-06-15
the filtrate to dryness, add 5ml of 1% hydrochloric acid solution to the residue to dissolve, filter, and add sodium
GC Identification of Watermelon Shuang Runhou Tablets, GC Identification of Jufang Zhibao San
Time of Update: 2022-06-15
Take about 15mg of Borneol reference substance, accurately weigh it, place it in a 100ml measuring flask, add the internal standard solution to dissolve and dilute to the mark, shake well, and get it .
Determination of ginsenoside Re, Rb1 and notoginsenoside R1 in Panax notoginseng tablets
Time of Update: 2022-06-13
Table 19-20 HPLC determination of ginsenoside Re, Rb1, and notoginsenoside R1 content in Sanqi tablets gradient elution conditions Chromatographic column: Zorbax XDB C 18 , 4.
Determination of Schisandrin A in Shenqi Wumaizi Tablets
Time of Update: 2022-06-13
Determination of Schisandrin A in Shenqi Wumaizi Tablets>【Prescription】Southern Schisandra 180g Codonopsis 60g Astragalus 120g Fried Jujube Seed 30g
Die installation method of rotary tablet press
Time of Update: 2022-06-09
Rotary tablet presses are used to press various granular materials into round tablets and special-shaped tablets . Its structure
AbbVie's JAK inhibitor "Upatinib Sustained-Release Tablets" is expected to be approved in China in the near future
Time of Update: 2022-05-29
It is hoped that AbbVie Upatinib Sustained-Release Tablets will be approved in China as soon as possible, which will provide new treatment options for Chinese patients with atopic dermatitis!References:[1] Drug registration progress query on NMPA official website.
Fosun Pharma's holding subsidiary ORIN1001 tablet was approved for drug clinical trial
Time of Update: 2022-05-28
On February 22, Fosun Pharma announced that its holding subsidiary Fosun Hongchuang received approval from the State Drug Administration for the approval of the ORIN1001 tablet developed
Hengrui Medicine's GnRH receptor antagonist SHR7280 tablets was approved for clinical use
Time of Update: 2022-05-28
Excessive levels of estradiol hormone can lead to the occurrence and development of uterine fibroids.
China Resources Pharma's China Pharmaceutical Research Innovative Drug NIP003 Tablets Obtained Clinical Approval
Time of Update: 2022-05-27
Institute, a subsidiary of China Resources Pharma, obtained the "Notice of Drug Clinical Trial Approval" issued by the NMPA, and was approved for clinical use in the prevention of arteriovenous thrombosis. test
Chinese pharmaceutical subsidiary Tianfang Co., Ltd. Risedronate Sodium Tablets passed the consistency evaluation
Time of Update: 2022-05-27
On March 10, 2022, Sinopharm announced that its subsidiary Tianfang Co.
Osteoporosis .
A new drug for the treatment of hyperammonemia, Kaglutamic acid dispersible tablets, was declared for listing in China
Time of Update: 2022-05-26
According to public information, this is a rare disease treatment product called Carbaglu, which was initially approved overseas for hyperammonemia caused by N-acetylglutamate synthase (NAGS) deficiency .
Huahai Pharmaceutical's Nebivolol Tablets Obtained FDA Approval Number
Time of Update: 2022-05-24
, Huahai Pharmaceutical has invested approximately RMB 10. 73 million in research and development expenses in the nebivolol tablet project . >
Bihuan Pharmaceutical's Doxycycline Hydrochloride Tablets Passed the Consistency Evaluation of Generic Drugs
Time of Update: 2022-05-21
com database, there are currently 61 domestic manufacturers of doxycycline hydrochloride tablets of the same variety, of which 3 manufacturers can be queried for the current consistency evaluation, namely the original research Pfizer Pharmaceutical Co.
The marketing application of Shandong New Era Metformin Hydrochloride Sustained-Release Tablets was approved
Time of Update: 2022-05-20
On April 15, NMPA released the latest drug approval information, and Shandong New Era Pharmaceuticals' metformin hydrochloride sustained-release tablet category 4 generic
100 million-level best-selling cardiovascular drug Chengdu Bitedigoxin Tablets is the first to review
Time of Update: 2022-05-18
On April 19, NMPA's official website released the latest information on approved drugs, and Chengdu Beite Pharmaceutical's digoxin tablets were the first to be reviewed .
"Jianzhi" $8 billion Erye Pharmaceutical Rivaroxaban Tablets Enters Administrative Approval Stage
Time of Update: 2022-05-15
2021H1 China's public medical institutions' terminal antithrombotic drug products TOP5 Source: Minet.